Literature DB >> 6609634

Portal hypertension complicating sarcoid liver disease: case report and review of the literature.

H Tekeste, F Latour, R E Levitt.   

Abstract

A rare case of severe liver disease in a patient with systemic sarcoidosis is reported. The liver pathology progressed from sarcoid granulomas early in the course to chronic active hepatitis and cirrhosis with complicating portal hypertension and bleeding esophageal varices. The literature on portal hypertension due to hepatic sarcoidosis is reviewed and the role of coexisting disease, portasystemic shunts, and steroid therapy is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6609634

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.

Authors:  H Bécheur; H Dall'osto; G Chatellier; M C Charton-Bain; J M Aubertin; A Attar; F Bloch; J P Petite
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

2.  Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution.

Authors:  David T Fetzer; Mitchell A Rees; Anil K Dasyam; Mitchell E Tublin
Journal:  Eur Radiol       Date:  2016-01-16       Impact factor: 5.315

3.  Diagnostic and therapeutic challenges of hepatic sarcoidosis.

Authors:  Haider Mosea; James Gotto; Zubair Khan
Journal:  BMJ Case Rep       Date:  2011-07-15

4.  Primary peritoneal sarcoidosis.

Authors:  L E Robertson; J T Cunningham
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

5.  Hepatic and splenic sarcoidosis: ultrasound and MR imaging.

Authors:  A Kessler; D G Mitchell; H L Israel; B B Goldberg
Journal:  Abdom Imaging       Date:  1993

6.  Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course.

Authors:  Serena M Bagnasco; Srinivas Gottipati; Edward Kraus; Nada Alachkar; Robert A Montgomery; Lorraine C Racusen; Lois J Arend
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.